Raffy Kazandjian

Permanent advisor Biotech

  • Over 20 years of venture capital experience
  • Former President of CDC-Innovation, with €300m+ AuM of which €240m he raised directly. 
  • 70 investments in technology start-ups, incl. ExonHit Therapeutics, Actelion, Cryocath Technologies, Entomed (founded by 2011 Nobel Prize winner, Jules Hoffmann), Integra, NetCentrx, Freever, Cellectis, 
  • Personal track-record of 7 IPOS.
  • Started with P&G, two French-based start-ups (Biovector Therapeutics and Medafor), Sanofi-Synthelabo 
  • Board member of numerous life science companies, several of which were successfully listed

Latest articles

Geopolitics

Scénarios géostratégiques baltes : note de l’Institut Montaigne

Mentionnée notamment par le Monde Rappel de l’article 42 §7 du Traité More

Corporate Venture

Mantra’s Niche Private Equity Index Q4 2025

Published 4 November 2025. Mantra’s Index highlights the niche private equity strategies More

Artificial Intelligence

CB Insights’ State of AI Global Q3 2025

Growing market (#3 by recruitments): Defence & National security AI copilots